Predictive And Presymptomatic Testing Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Predictive And Presymptomatic Testing Market?
The uptick in the occurrence of genetic disorders is anticipated to stimulate the expansion of the predictive and presymptomatic testing market. Genetic disorders, diseases triggered by deformities in deoxyribonucleic acid (DNA) such as gene mutations and chromosome alterations, include ailments like cystic fibrosis and down syndrome. The surge in genetic disorders is linked to factors like increased maternal age, environmental influences, and improved diagnostic methodologies. The critical function of predictive and presymptomatic testing is to lessen the instance of genetic disorders by identifying those at risk prior to the appearance of symptoms. This proactive method enables early interventions or changes in lifestyle which can aid in the prevention or reduction in severity of these disorders. As an example, as per the American Society of Gene and Cell Therapy, a non-profit medical and scientific group based in the US, the number of gene therapies in Phase III clinical trials saw an increase of 10% in Q3 2023, the first escalation since Q3 2022. Hence, the swelling prevalence of genetic disorders is propelling the predictive and presymptomatic testing market forward.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20594&type=smp
#What is the Projected CAGR for the Predictive And Presymptomatic Testing Market Size from 2025 to 2034?
In recent years, the predictive and presymptomatic testing market has experienced a remarkable expansion. According to forecasts, the market, valued at $5.24 billion in 2024, will rise to an estimated $5.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The growth experienced in the previous years can be credited to several factors. These include a surge in the occurrence of genetic disorders, an increasing requirement for the early detection of chronic diseases, a rising rate of cancer cases, a growing acceptance of personalized medicine, and an increased availability of direct-to-consumer genetic tests.
Rapid expansion is anticipated in the predictive and presymptomatic testing market in the approaching years, with its value projected to reach $8.47 billion by 2029, a feat representing a compound annual growth rate (CAGR) of 10.1%. This projected growth during the forecast period can be ascribed to a surge in the need for early disease diagnosis, increased investment in genomics and biotechnology, escalating demand for non-intrusive testing procedures, an expansion in the aged population, and increased initiatives in precision medicine. Key trends for this period include the embracing of individualized medicine, the use of home testing kits, the merger of genomics and substantial data, the advancement of next-generation sequencing (NGS) technologies, and the incorporation of predictive testing in the development of drugs.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20594
What New Market Trends Are Reshaping thePredictive And Presymptomatic Testing Market and Its Opportunities?
Leading enterprises in the predictive and presymptomatic testing industry are pioneering innovative exams such as multigene testing. This kind of testing allows for the simultaneous assessment of numerous genes to detect potential health hazards and allow for early protective measures. Multigene testing is a means of medical diagnosis that scrutinizes several genes concurrently to pinpoint genetic changes or irregularities that could be linked to particular diseases or conditions. This contributes to personalized medicine and tailored treatment plans. For instance, in July 2022, the biotechnology research company based in Australia, Genetic Technologies Limited, joined forces with Siles Health, a women’s healthcare center also in Australia. Together, they inaugurated the geneType Multi-Risk Test aimed at delivering thorough risk evaluations for patients. The geneType Multi-Risk Test is an exhaustive genetic testing tool that gauges a patient’s risk for several severe illnesses, including breast and colorectal cancer, as well as type 2 diabetes. The goal of the test is to utilize both inherited and sporadic genetic factors in formulating personalized healthcare methods leading to early treatments.
Who Are the Leading Market Players Fueling Growth in the Predictive And Presymptomatic Testing Market Trend?
Major companies operating in the predictive and presymptomatic testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Mayo Clinic, Quest Diagnostics Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Peter MacCallum Cancer Centre, Myriad Genetics Inc., SomaLogic Inc., Siteman Cancer Center, Dante Labs S.R.L., Mapmygenome, Manipal Health Enterprises, Gene Vision, Reliance Diagnostic, GenepoweRx, Personal Genomics, Apollo Hospitals Enterprise Limited, Cardio Diagnostics Inc.
Order Your Report Now For A Swift Delivery:
How is the Global Predictive And Presymptomatic Testing Market Segemented?
The predictive and presymptomatic testing market covered in this report is segmented –
1) By Test Type: Predictive Testing, Presymptomatic Testing
2) By Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Other Applications
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Predictive Testing: Genetic Testing for Inherited Conditions, Cancer Risk Prediction, Cardiovascular Disease Prediction, Neurodegenerative Disease Risk Prediction, Genetic Screening for Autosomal Dominant Disorders, Prenatal Predictive Testing, Pharmacogenomic Testing
2) By Presymptomatic Testing: Huntington’s Disease Testing, Hereditary Cancer Risk Testing, Cystic Fibrosis Presymptomatic Testing, Early-Onset Alzheimer’s Disease Testing, Carrier Screening for Genetic Conditions, Testing for Early Signs of Neurodegenerative Diseases, Presymptomatic Genetic Testing for Familial Diseases
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20594&type=smp
Which Geographics are Influencing the Growth of the Predictive And Presymptomatic Testing Market?
North America was the largest region in the predictive and presymptomatic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive and presymptomatic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Predictive And Presymptomatic Testing Market 2025, By The Business Research Company:
Predictive Vehicle Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-vehicle-technology-global-market-report
Predictive Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-analytics-global-market-report
Predictive Maintenance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-maintenance-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
